```html

Physiologic Newborn Jaundice – A Complete Guide for Parents

Overview

What it is: Neonatal physiologic jaundice is a common, usually harmless rise in bilirubin levels that appears in the first week of life. Bilirubin is a yellow‑pigmented breakdown product of red blood cells. In newborns the liver is immature and may not process bilirubin quickly enough, leading to a yellow discoloration of the skin and sclera (the whites of the eyes).

Who it affects: All term and near‑term infants are at risk, but the condition is most typical in babies born between 37‑42 weeks gestation. Pre‑term infants (<37 weeks) often develop jaundice earlier and may have higher bilirubin levels, yet it is still considered physiologic when it follows the expected pattern.

Prevalence: According to the World Health Organization (WHO) and the American Academy of Pediatrics (AAP), up to 60 % of term infants develop visible jaundice, with the majority resolving without intervention. In the United States, about 1 in 5 newborns requires phototherapy for physiologic jaundice, reflecting a high but manageable incidence.<sup>CDC</sup>

Symptoms

Physiologic jaundice usually follows a predictable progression. The classic “rule of 6” (visible at or after 6 hours, peaks around day 3‑5, resolves by day 7‑10) can help parents recognize it.

• Yellow skin: Begins on the face and progresses down the chest, abdomen, and limbs. The yellow hue is most obvious in natural light.
• Yellow eyes (scleral icterus): The whites of the eyes turn yellow before the skin in many cases.
• Feeding changes: The baby may be slightly less eager to breast‑feed due to a mild “taste” change, though most infants maintain normal feeding patterns.
• Sleepiness or decreased activity: Mild lethargy can accompany higher bilirubin levels but should not be severe.
• Normal urine and stool: In physiologic jaundice, urine remains yellow and stool is typically yellow‑green. Darker stools may indicate a problem.
• No fever or signs of infection: Fever, rash, or poor temperature regulation suggest a pathologic process.

Causes and Risk Factors

Underlying mechanism

Physiologic jaundice results from a combination of three normal neonatal processes:

1. Increased bilirubin production: Newborns have a higher red‑blood‑cell turnover (around 5‑6 % of total red cells per day) than adults.
2. Immature glucuronidation: The liver enzyme UDP‑glucuronosyltransferase (UGT1A1) is under‑expressed for the first few days, delaying conversion of bilirubin into a water‑soluble form that can be excreted.
3. Reduced excretion: Both the intestines and kidneys are not fully efficient at eliminating bilirubin initially.

Risk factors that increase the likelihood of higher bilirubin levels

• Breastfeeding difficulties (poor latch, infrequent feeds) – leads to dehydration and reduced bilirubin elimination.
• Maternal diabetes or a baby who is large‑for‑gestational‑age (LGA).
• Prematurity (<37 weeks) or being small‑for‑gestational‑age (SGA).
• East Asian or Mediterranean ancestry – genetic variations in UGT1A1 are more common.
• Blood‑type incompatibility (e.g., ABO or Rh) – can cause a mild hemolytic component that pushes bilirubin higher.
• Prolonged rupture of membranes (>18 hours) – predisposes to infection‑related jaundice.
• Use of certain medications in the mother (e.g., sulfonamides) that interfere with bilirubin metabolism.

Diagnosis

A diagnosis of physiologic jaundice is clinical but supported by objective testing.

Physical examination

• Visual assessment of skin and scleral coloration.
• Timing of onset (usually after 24 hours in term infants).
• Evaluation of feeding adequacy and hydration status.

Laboratory tests

• Serum total bilirubin (TSB): Measured via heel‑stick or venous sample. Levels are plotted on age‑specific phototherapy nomograms (e.g., AAP “Bhutani” curves).<sup>AAP</sup>
• Direct (conjugated) bilirubin: Helps differentiate physiologic (predominantly indirect) from pathologic cholestatic jaundice.
• Optional: Complete blood count (CBC) and blood type/Coombs test if hemolysis is suspected.

Additional tools

Transcutaneous bilirubin meters (TcB) provide a non‑invasive estimate and are useful for screening, especially in community settings. However, a confirmatory serum test is required before initiating phototherapy.

Treatment Options

Most cases of physiologic jaundice resolve with minimal intervention. Treatment decisions are based on the infant’s age in hours, bilirubin level, and presence of risk factors.

1. Enhanced feeding

• Breast‑feed at least 8‑12 times per 24 hours (≈30 mL per feed).
• For bottle‑fed infants, offer 60‑90 mL/kg/day of formula.
• Frequent feeding promotes intestinal motility, which helps eliminate bilirubin via stool.

2. Phototherapy

Indicated when bilirubin reaches the treatment threshold on the AAP nomogram or rises rapidly.

• Conventional (hospital‑based) phototherapy: Blue‑light (460‑490 nm) blankets or lights.
• LED phototherapy: More efficient, lower heat output; increasingly the standard of care.
• Typical duration: 12‑48 hours, with bilirubin checks every 4‑6 hours.
• Adverse effects are rare but may include transient “bronze‑baby” skin discoloration, loose stools, and mild temperature changes.

3. Intravenous immunoglobulin (IVIG)

Used only when there is significant hemolysis due to ABO or Rh incompatibility and phototherapy is insufficient. Not a routine treatment for physiologic jaundice.<sup>CDC</sup>

4. Exchange transfusion

Reserved for extreme hyperbilirubinemia (>25 mg/dL) with risk of kernicterus. Extremely rare in physiologic cases.

5. Lifestyle & supportive measures

• Expose the baby to indirect sunlight for brief periods (10‑15 minutes) after feeding, if safe and away from direct UV rays.
• Maintain a warm ambient temperature (23‑25 °C) to prevent hypothermia, which can worsen jaundice.

Living with Jaundice of the Newborn (Physiologic)

Daily management tips for parents

• Track feedings: Keep a log of feeding times and volumes to ensure the baby is getting enough calories.
• Monitor bilirubin trends: If discharged home, many pediatric offices will schedule a follow‑up lab check at 48‑72 hours of life.
• Skin checks: Examine the baby’s skin under natural light every day. The jaundice should move downward and fade.
• Maintain hydration: Offer expressed breast milk or formula after each diaper change if the infant seems sluggish.
• Bathing: Gentle sponge baths are fine. Avoid using harsh soaps that may irritate already sensitive skin.
• Phototherapy care at home: If you receive a home phototherapy unit, keep the baby’s eyes protected with the supplied patches, and ensure the light source stays at the recommended distance.
• Family support: Jaundice can be stressful; involve partners and family members in feeding and soothing duties.

Prevention

While physiologic jaundice cannot be completely prevented, certain measures can lower the risk of high bilirubin levels and reduce the need for treatment.

• Early and frequent breastfeeding: Initiate within the first hour of life and aim for at least 8–10 feeds per day.
• Adequate prenatal care: Managing maternal diabetes, hypertension, and preventing prolonged rupture of membranes helps reduce newborn jaundice risk.
• Prompt newborn assessment: A thorough exam and bilirubin screening before discharge allow early identification.
• Avoid unnecessary medications: Some drugs (e.g., sulfonamides, certain antibiotics) can displace bilirubin from albumin; discuss medication safety with the pediatrician.

Complications

When physiologic jaundice is left untreated or bilirubin rises to dangerous levels, the following complications can occur:

• Kernicterus (bilirubin‑induced neurologic dysfunction): Bilirubin crosses the blood‑brain barrier, causing irreversible brain injury, seizures, deafness, or cerebral palsy.
• Acute bilirubin encephalopathy: Early, potentially reversible neurologic signs such as lethargy, hypotonia, or high‑pitched cry.
• Feeding difficulties: Severe jaundice can depress the newborn’s suck‑swallow reflex, leading to dehydration.
• Bronze baby syndrome: A temporary skin discoloration seen after prolonged phototherapy; benign and self‑limited.

Early detection and treatment virtually eliminate the risk of kernicterus in physiologic jaundice.<sup>Mayo Clinic</sup>

When to Seek Emergency Care

---

Sources: American Academy of Pediatrics (AAP) – “Management of Hyperbilirubinemia in the Newborn”, 2022; Centers for Disease Control and Prevention (CDC); Mayo Clinic; National Institutes of Health (NIH) – Neonatal Jaundice; World Health Organization (WHO). All links accessed April 2026.

```